target audience: TECH SUPPLIER Publication date: Oct 2024 - Document type: IDC Survey - Doc Document number: # US52643224
IDC's Life Science Industry Generative AI Survey, August 2024
Content
- 54 slides
Get More
When you purchase this document, the purchase price can be applied to the cost of an annual subscription, giving you access to more research for your investment.
Related Links
Abstract
This IDC Survey reviews the current and forecast levels of generative AI (GenAI) adoption by the life science industry and determines who are some of the key GenAI strategic partners for this industry today and how this will change over time, the types of models used, the use of AI platforms, the existence of responsible AI frameworks, ethics councils, and sustainable AI strategies.
IDC's life science research team conducted a survey in North America on 100 pharmas and biotechs to understand the current and future status of GenAI adoption in the life science industry. The survey was conducted in August 2024.
The goal of the survey is to understand how GenAI is having an impact across the life science value chain, determine which are the key use cases where the industry is seeing the maximum ROI, analyze how hiring plans and investment strategies evolving, and reflect upon the key challenges impacting the adoption of GenAI.
It draws comparison between the implementation of POCs and the deployment of use cases across life science R&D and commercial.
This IDC Survey also provides commentary on evolving trends as compared with a similar survey conducted in November 2023 and is an important and insightful piece of work for life science companies that are implementing GenAI strategies within their organizations.